ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Scope & Guideline

Transforming Research into Therapeutic Solutions

Introduction

Delve into the academic richness of ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0004-069x
PublisherDE GRUYTER POLAND SP Z O O
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 1954 to 1957, from 1959 to 1977, from 1979 to 2024
AbbreviationARCH IMMUNOL THER EX / Arch. Immunol. Ther. Exp.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND

Aims and Scopes

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS focuses on the intersection of immunology and experimental therapies, highlighting innovative research that advances our understanding of immune responses and therapeutic interventions.
  1. Immunological Mechanisms:
    The journal extensively covers the mechanisms of immune responses, including topics like T cell function, cytokine signaling, and the role of various immune cells in disease processes.
  2. Therapeutic Innovations:
    A key focus is on experimental therapies and innovations in immunotherapy, particularly regarding conditions like cancer, autoimmune diseases, and infectious diseases.
  3. Translational Research:
    The journal emphasizes studies that bridge laboratory findings with clinical applications, aiming to translate basic immunological research into therapeutic strategies.
  4. Pathogen-Host Interactions:
    Research exploring the dynamics between pathogens and host immune responses, including studies on viral infections and autoimmune responses.
  5. Regulatory and Tolerogenic Mechanisms:
    The journal addresses how immune tolerance and regulation can impact disease progression and therapy, especially in transplantation and autoimmune disorders.
  6. Emerging Technologies in Immunology:
    The incorporation of new technologies such as genomics, proteomics, and artificial intelligence in understanding immune responses and developing therapies.
Recent publications indicate a shift towards several emerging themes within the journal, reflecting current trends in immunology and therapeutic research.
  1. Cancer Immunotherapy:
    An increasing number of studies focus on immunotherapeutic approaches in oncology, highlighting CAR-T cell therapy and other innovative strategies to enhance anti-tumor immunity.
  2. Impact of Microbiome on Immunity:
    Research exploring the role of gut microbiota in modulating immune responses and its implications for various diseases is gaining traction, indicating a broader interest in microbiome-immune interactions.
  3. Artificial Intelligence in Immunology:
    There is a growing interest in the application of artificial intelligence and big data analytics to understand immune responses and improve therapeutic strategies.
  4. Vaccine Responses and Immunogenicity:
    With the emergence of new pathogens, studies assessing vaccine efficacy and immune responses, especially in the context of COVID-19, are increasingly prevalent.
  5. Personalized Medicine in Immunotherapy:
    The trend towards personalized approaches in immunotherapy, including tailored treatments based on individual genetic and immunological profiles, is becoming more prominent.

Declining or Waning

While some areas of research remain prominent, others have shown a decline in focus, suggesting shifting priorities in the journal's scope.
  1. Traditional Autoimmune Disease Models:
    Research using conventional autoimmune disease models appears to be waning, possibly due to a shift towards more complex and translational models that better mimic human diseases.
  2. Single Disease Focus:
    There is a noticeable decline in studies focusing solely on individual diseases, with more research now emphasizing holistic and systems biology approaches.
  3. Basic Immunology without Clinical Relevance:
    Studies that explore basic immunological principles without clear clinical implications are becoming less frequent, reflecting a trend towards research with direct therapeutic applications.

Similar Journals

HUMAN IMMUNOLOGY

Pioneering Insights into Immune Responses
Publisher: ELSEVIER SCIENCE INCISSN: 0198-8859Frequency: 12 issues/year

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

EUROPEAN JOURNAL OF IMMUNOLOGY

Advancing Immunology Through Pioneering Research
Publisher: WILEYISSN: 0014-2980Frequency: 12 issues/year

Welcome to the European Journal of Immunology, a premier peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Established in 1971 and published by Wiley, this esteemed journal has been consistently ranked in the top quartile (Q1) across its categories, highlighting its significant impact within the scientific community. With an impressive Scopus ranking, the journal occupies the 64th position in Immunology and Allergy and the 74th in the broader sector of Immunology and Microbiology, demonstrating its vital role in driving innovation and knowledge in immunological studies. The European Journal of Immunology publishes high-quality original research, comprehensive reviews, and insightful commentary, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to understanding the complexities of the immune system. Although not an open-access journal, it offers various subscription options to ensure that institutions and individuals can access pivotal research that shapes the future of immunology.

Innate Immunity

Empowering Researchers in the Realm of Innate Immunity
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4259Frequency: 6 issues/year

Innate Immunity, published by SAGE Publications Ltd, serves as a vital platform for disseminating cutting-edge research in the fields of immunology, microbiology, cell biology, and infectious diseases. With an ISSN of 1753-4259 and an E-ISSN of 1753-4267, this journal has been a prominent contributor to the academic community since its inception in 1996, focusing on the innate immune response and its implications for health and disease. Holding a respectable impact factor and categorized in the Q2 and Q3 quartiles across various relevant domains, Innate Immunity ranks competitively in major databases, including Scopus, where it appears in the top 75th percentile for Infectious Diseases. Researchers and professionals are encouraged to explore its wealth of articles that are pivotal in bridging fundamental immunology with clinical applications, fostering a deeper understanding of immune mechanisms vital for combating human diseases.

INFLAMMATION RESEARCH

Illuminating the pathways of inflammation research.
Publisher: SPRINGER BASEL AGISSN: 1023-3830Frequency: 12 issues/year

INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.

INTERNATIONAL IMMUNOLOGY

Pioneering Research at the Intersection of Immunology and Medicine.
Publisher: OXFORD UNIV PRESSISSN: 0953-8178Frequency: 12 issues/year

INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.

INTERNATIONAL REVIEWS OF IMMUNOLOGY

Illuminating the Path to Immunological Innovation
Publisher: TAYLOR & FRANCIS INCISSN: 0883-0185Frequency: 6 issues/year

INTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.

NATURE IMMUNOLOGY

Transforming research into real-world applications in immunology.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

Immunological Medicine

Fostering Collaboration in Immunological Breakthroughs
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

CURRENT OPINION IN IMMUNOLOGY

Connecting Scholars in the World of Immunology
Publisher: CURRENT BIOLOGY LTDISSN: 0952-7915Frequency: 6 issues/year

CURRENT OPINION IN IMMUNOLOGY is a prestigious journal dedicated to the dynamic field of immunology, published by CURRENT BIOLOGY LTD in the United Kingdom. With an ISSN of 0952-7915 and an E-ISSN of 1879-0372, this journal has been a cornerstone of scholarly communication since its inception in 1988 and continues to disseminate cutting-edge research and reviews aimed at advancing our understanding of immune responses. Holding a remarkable Q1 ranking in both Immunology and Allergy categories for 2023, it ranks impressively within the top percentiles in its field, securing 27th233 in Immunology and Allergy and 31st out of 236 in Immunology and Microbiology. Emphasizing high-impact research, the journal provides researchers, professionals, and students with valuable insights into emerging trends and critical developments. As a vital resource in immunological research, it serves as a platform for disseminating innovative findings, fostering collaboration, and enhancing scholarly exchange in a rapidly evolving scientific landscape.

TRENDS IN IMMUNOLOGY

Shaping the Future of Immunology Through Comprehensive Reviews
Publisher: CELL PRESSISSN: 1471-4906Frequency: 12 issues/year

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.